Department of Cardiovascular Medicine, Chiba University Graduate School of Medicine, Chiba, Japan.
Healthcare Management Research Center, Chiba University Hospital, Chiba, Japan.
BMC Neurol. 2023 Nov 13;23(1):402. doi: 10.1186/s12883-023-03454-6.
BACKGROUND/OBJECTIVE: Few reports have directly compared the outcomes of patients with acute ischemic stroke (AIS) who are managed in a stroke care unit (SCU) with those who are managed in an intensive care units (ICU). This large database study in Japan aimed to compare in-hospital mortality between patients with AIS admitted into SCU and those admitted into ICU.
Patients with AIS who were admitted between April 1, 2014, and March 31, 2019, were selected from the administrative database and divided into the SCU and ICU groups. We calculated the propensity score to match groups for which the admission unit assignment was independent of confounding factors, including the modified Rankin scale (mRS) score. The primary outcome was in-hospital mortality, and secondary outcomes were the mRS score at discharge, length of stay (LOS), and total hospitalization cost.
Overall, 8,683 patients were included, and 960 pairs were matched. After matching, the in-hospital mortality rates of the SCU and ICU groups were not significantly different (5.9% vs. 7.9%, P = 0.106). LOS was significantly shorter (SCU = 20.9 vs. ICU = 26.2 days, P < 0.001) and expenses were significantly lower in the SCU group than in the ICU group (SCU = 1,686,588 vs. ICU = 1,998,260 yen, P < 0.001). mRS scores (score of 1-3 or 4-6) at discharge were not significantly different after matching. Stratified analysis showed that the in-hospital mortality rate was lower in the ICU group than in the SCU group among patients who underwent thrombectomy.
In-hospital mortality was not significantly different between the ICU and SCU groups, with significantly lower costs and shorter LOS in the SCU group than in the ICU group.
背景/目的:鲜有研究直接比较在卒中护理单元(SCU)和重症监护病房(ICU)接受治疗的急性缺血性脑卒中(AIS)患者的结局。本项在日本开展的大型数据库研究旨在比较 AIS 患者入住 SCU 和 ICU 的院内死亡率。
从行政数据库中选取 2014 年 4 月 1 日至 2019 年 3 月 31 日期间收治的 AIS 患者,将其分为 SCU 和 ICU 组。我们计算倾向评分以匹配入院单元分配不受混杂因素影响的患者,包括改良Rankin 量表(mRS)评分。主要结局为院内死亡率,次要结局为出院时的 mRS 评分、住院时间(LOS)和总住院费用。
共有 8683 例患者纳入研究,960 对患者匹配。匹配后,SCU 和 ICU 组的院内死亡率无显著差异(5.9%比 7.9%,P=0.106)。SCU 组 LOS 显著缩短(SCU=20.9 天,ICU=26.2 天,P<0.001),费用显著低于 ICU 组(SCU=1686588 日元,ICU=1998260 日元,P<0.001)。匹配后出院时 mRS 评分(1-3 分或 4-6 分)无显著差异。分层分析显示,接受取栓治疗的患者 ICU 组院内死亡率低于 SCU 组。
SCU 组和 ICU 组的院内死亡率无显著差异,但 SCU 组的费用和 LOS 显著低于 ICU 组。